Cargando…
DCAF12 and HSPA1A May Serve as Potential Diagnostic Biomarkers for Myasthenia Gravis
BACKGROUND: Myasthenia gravis (MG) is an autoimmune disease that severely affects the life quality of patients. This study explores the differences in immune cell types between MG and healthy control and the role of immune-related genes in the diagnosis of MG. METHODS: The GSE85452 dataset was downl...
Autores principales: | Nong, Weidong, Huang, Fang, Mao, Fengping, Lao, Dayuan, Gong, Zhuowei, Huang, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155969/ https://www.ncbi.nlm.nih.gov/pubmed/35655486 http://dx.doi.org/10.1155/2022/8587273 |
Ejemplares similares
-
Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case–Control Study
por: Zhou, Shaodan, et al.
Publicado: (2023) -
Risk Factors and Prognosis in Anti-NMDA Receptor Encephalitis Patients with Disturbance of Consciousness
por: Gong, Zhuowei, et al.
Publicado: (2023) -
Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis
por: Li, Lanqi, et al.
Publicado: (2022) -
Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007) -
Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)